封面
市场调查报告书
商品编码
1907818

全球週边栓塞保护装置市场 - 市场规模(按细分市场划分)、占有率、监管、报销、干预措施及预测(至 2036 年)

Peripheral Embolic Protection Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

出版日期: | 出版商: GlobalData | 英文 | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

本报告对全球週边栓塞保护装置市场进行了研究和分析,提供了区域市场规模、关键趋势、创新产品和技术以及竞争格局等资讯。

市场模型的主要组成如下:

已上市的外周栓塞保护装置及不断变化的竞争格局

  • 主要行业趋势探讨
  • 週边栓塞保护装置市场各细分市场的年度收入及市场展望(2015-2036 年)
  • 各细分市场的总干预次数、单位销售、平均售价和市场价值的详细数据

全球、区域与国家各市场的探讨层级

  • 按地区和国家细分的定性市场资讯讨论
  • 週边栓塞保护装置市场的SWOT分析
  • 外周栓塞保护装置市场竞争动态与趋势讨论

全面的视角,包括对医疗保健系统的概述,有助于深入了解市场。此外,市场参与部分提供有关报销政策和监管环境的信息,从而可以更深入地了解市场动态。

  • 各国医疗保健系统概述
  • 报销政策
  • 医疗科技监管环境

目标公司

  • Medtronic Plc
  • Abbott Laboratories
  • Boston Scientific Corp
  • Cordis Corp
  • 其他
简介目录
Product Code: GDME671MM

Peripheral Embolic Protection Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

Peripheral Embolic Protection Devices are used to capture and remove plaque debris that is dislodged during interventional process. Peripheral Embolic Protection Devices used in the lower extremity, carotid and renal arteries are included here. Various methods have been employed in attempts to reduce distal embolization events as a result of endovascular interventions. Present technologies for Embolic Protection Devices (EPD) employ three important strategies: distal occlusion, proximal occlusion and distal filtration.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Peripheral Embolic Protection Devices market and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Peripheral Embolic Protection Devices market revenue by segment and market outlooks from 2015-2036.
  • Granular data on total interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Peripheral Embolic Protection Devices market.
  • Competitive dynamics insights and trends provided Peripheral Embolic Protection Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, Cordis Corp, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Peripheral Embolic Protection Devices marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving Peripheral Embolic Protection Devices market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Peripheral Embolic Protection Devices market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Peripheral Embolic Protection Devices market from 2015-2036.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.